We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-41%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$147M
AUM Growth
-$523M
Cap. Flow
-$201M
Cap. Flow %
-136.49%
Top 10 Hldgs %
64.77%
Holding
167
New
23
Increased
38
Reduced
54
Closed
36

Top Buys

Rank Stock Value
1
GEVO icon
Gevo
GEVO
+$20.1M
2
DOGZ icon
Dogness International Corp
DOGZ
+$8.37M
3
ONCO icon
Onconetix
ONCO
+$5.5M
4
MMAT
Meta Materials Inc. Common Stock
MMAT
+$3.83M
5
NEPT
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
+$3.81M

Top Sells

Rank Stock Value
1
CNTX icon
Context Therapeutics
CNTX
+$2.53M
2
HMCO
HumanCo Acquisition Corp. Class A Common Stock
HMCO
+$1.42M
3
USWS
U.S. Well Services, Inc. Class A Common Stock
USWS
+$1.07M
4
GYRE icon
Gyre Therapeutics
GYRE
+$871K
5
AGMH icon
AGM Group Holdings
AGMH
+$859K

Sector Composition

Rank Sector Weight
1 Healthcare 12.65%
2 Materials 8.79%
3 Technology 5.39%
4 Consumer Discretionary 3.75%
5 Consumer Staples 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$26.4M 17.97%
+700
New +$287K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.9B
$20.7M 14.12%
1,225
-1,515
-55% -$283K
DJT icon
3
PUT
Trump Media & Technology Group
DJT
$2.87B
$13M 8.87%
5,399
-4,912
-48% -$205K
GEVO icon
4
Gevo
GEVO
$372M
$12.9M 8.79%
+5,486,831
New +$20.1M
DJT icon
5
CALL
Trump Media & Technology Group
DJT
$2.87B
$5.96M 4.06%
2,468
-2,844
-54% -$119K
PSTH
6
CALL
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$4.09M 2.78%
2,047
+40
+2% +$795
DOGZ icon
7
Dogness International Corp
DOGZ
$12.8M
$3.81M 2.59%
+104,753
New +$8.37M
BCTXW
8
PUT
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$2.89M 1.96%
5,001
-1,518
-23% -$4.85K
TCDA
9
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
$2.68M 1.82%
2,771
-1,967
-42% -$18.7K
MMAT
10
DELISTED
Meta Materials Inc. Common Stock
MMAT
$2.64M 1.8%
+25,673
New +$3.83M
COCP icon
11
Cocrystal Pharma
COCP
$12M
$2.41M 1.64%
490,744
+23,074
+5% +$123K
PMCB icon
12
PharmaCyte Biotech
PMCB
$6.44M
$2.38M 1.62%
1,061,411
-214,057
-17% -$468K
XNTK icon
13
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.05B
$2.12M 1.45%
+286
New +$33.2K
VRPX
14
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$1.78M 1.21%
4,238
+217
+5% +$89K
AIOS
15
AIOS Tech
AIOS
$38.8M
$1.74M 1.18%
13,764
-619
-4% -$93.6K
ZVRA icon
16
PUT
Zevra Therapeutics
ZVRA
$570M
$1.71M 1.16%
3,830
+179
+5% +$816
CAN
17
PUT
Canaan Creative
CAN
$182M
$1.66M 1.13%
5,153
+733
+17% +$2.77K
CAN
18
Canaan Creative
CAN
$182M
$1.4M 0.96%
436,015
+386,957
+789% +$1.46M
ZVRA icon
19
Zevra Therapeutics
ZVRA
$570M
$1.31M 0.89%
294,487
+35,707
+14% +$163K
ONCO icon
20
Onconetix
ONCO
$2.9M
$1.3M 0.88%
+4
New +$5.5M
LSTA icon
21
Lisata Therapeutics
LSTA
$9.38M
$1.24M 0.85%
156,266
-1,836
-1% -$15.1K
RCON icon
22
Recon Technology
RCON
$32.6M
$1.24M 0.84%
104,385
+10,954
+12% +$165K
ATOS icon
23
PUT
Atossa Therapeutics
ATOS
$21.8M
$1.22M 0.83%
744
-19
-2% -$299
OG
24
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$1.16M 0.79%
1,320,750
– –
PULM icon
25
Pulmatrix
PULM
$6.21M
$1.16M 0.79%
251,758
+13,800
+6% +$72.8K
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sabby Management held 167 positions worth $147M, down 78% from $670M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sabby Management withdrew a net $201M in Q2 2022, closing 36 positions and reducing 54 holdings. Its most notable exit was Context Therapeutics, an estimated $2.53M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.6% a quarter earlier, followed by Materials and Technology.

Against the trend, Sabby Management opened a new position in Gevo worth $12.9M.

  • Sabby Management's largest Q2 2022 buy was Gevo: 5,486,831 shares worth $12.9M.
  • Sabby Management added most to Canaan Creative in Q2 2022, an estimated $1.46M increase.
  • Sabby Management's biggest Q2 2022 reduction was HumanCo Acquisition Corp. Class A Common Stock, cutting an estimated $1.42M.
  • Sabby Management fully exited Context Therapeutics in Q2 2022, selling an estimated $2.53M.
  • Sabby Management's ten largest holdings make up 65% of its $147M portfolio in Q2 2022.
  • Sabby Management opened 23 new positions and closed 36 in Q2 2022.
  • Sabby Management's portfolio value fell 78% quarter-over-quarter to $147M.

Based on Sabby Management's 13F filing for Q2 2022, filed 15 Aug 2022.